ArticleJournal of thoracic disease2026
Cardiovascular and cerebrovascular related death among patients with esophageal cancer: an international multicenter study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Esophageal cancer (EC) has high incidence and mortality. Non-cancer deaths, particularly from cardiovascular and cerebrovascular related death (CCD), are increasing. The aim of this study is to investigate the risk factors associated with CCD in patients diagnosed with EC. Methods: The data of patients diagnosed with EC was retrospectively extracted from the Surveillance, Epidemiology, and End Results (SEER) database, the cause of death and follow-up information were collected. Mortality was calculated by cumulative incidence function (CIF), and the competing risk regression was utilized for risk factor analysis. In addition, cases of EC with in-hospital death in a Chinese hospital were collected, the cause of death and risk factors of CCD were analyzed. Results: The study included a total of 24,291 patients from SEER cohort and 133 patients from Chinese hospital cohort. During the follow-up period of SEER cohort, 21,272 (87.6%) patients succumbed to mortality, 931 (3.8%) of them were CCD, while 20,341 (83.7%) died from other causes. The median overall survival time was found to be 10 months [interquartile range (IQR), 4-28 months], age, sex, race, surgery, and tumor stage as independent risk factors for CCD. In the Chinese cohort, 133 patients with EC died in hospital, of which 25 (18.8%) were CCD, logistic regression showed that smoking history, history of hypertension, history of heart disease and high total cholesterol were independent risk factors for CCD. Conclusions: CCD is the primary cause among all non-cancer deaths in patients with EC, which seriously affects the expected survival of patients and should be prevented by risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.